1. Home
  2. SUNS vs TLSA Comparison

SUNS vs TLSA Comparison

Compare SUNS & TLSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sunrise Realty Trust Inc.

SUNS

Sunrise Realty Trust Inc.

HOLD

Current Price

$7.75

Market Cap

108.7M

Sector

Real Estate

ML Signal

HOLD

Logo Tiziana Life Sciences Ltd.

TLSA

Tiziana Life Sciences Ltd.

HOLD

Current Price

$1.00

Market Cap

124.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SUNS
TLSA
Founded
2023
2013
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
108.7M
124.0M
IPO Year
N/A
2017

Fundamental Metrics

Financial Performance
Metric
SUNS
TLSA
Price
$7.75
$1.00
Analyst Decision
Hold
Analyst Count
1
0
Target Price
$8.75
N/A
AVG Volume (30 Days)
53.5K
534.3K
Earning Date
05-14-2026
05-04-2026
Dividend Yield
16.17%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$70.81
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$8.84
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.34
$0.87
52 Week High
$11.78
$2.53

Technical Indicators

Market Signals
Indicator
SUNS
TLSA
Relative Strength Index (RSI) 44.47 42.55
Support Level $7.79 $0.87
Resistance Level $8.18 $1.45
Average True Range (ATR) 0.26 0.12
MACD -0.02 0.01
Stochastic Oscillator 34.18 38.07

Price Performance

Historical Comparison
SUNS
TLSA

About SUNS Sunrise Realty Trust Inc.

Sunrise Realty Trust Inc is a real estate investment trust company. It is focus on originating CRE debt investments and providing capital to high-quality borrowers and sponsors with transitional business plans collateralized by CRE assets with opportunities for near-term value creation, as well as recapitalization opportunities. It intends to create a diversified investment portfolio, targeting investments in senior mortgage loans, mezzanine loans, whole loans, B-notes, CMBS, and debt-like preferred equity securities across CRE asset classes and investment mix to include high-quality multi-family, condominiums, retail, office, hospitality, industrial, mixed-use, and specialty-use real estate. The company's portfolio is concentrated in the Southern U.S.

About TLSA Tiziana Life Sciences Ltd.

Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. The company's clinical pipeline includes drug assets for Non-Active Secondary Progressive Multiple Sclerosis, Multiple System Atrophy, Alzheimer's, and Amyotrophic Lateral Sclerosis. The company's mission is to design and deliver next-generation immunotherapies for neurodegenerative and neuroinflammatory diseases. The company's main immunotherapeutic candidate, Foralumab (TZLS-401), is being developed for Non-Active Secondary Progressive Multiple Sclerosis, Alzheimer's, and other CNS indications.

Share on Social Networks: